Systemic Anti-Cancer Therapy Delivery

National External Review

The treatment of cancer with medicines is commonly referred to as Systemic Anti-Cancer Therapy (SACT). Outcomes for patients following SACT are improving, but side effects are more common than with most medicines, and there is a higher risk of serious and potentially life-threatening complications.

This report presents an overview of progress in NHSScotland with the implementation of national standards to support the safe delivery of SACT and compliance with the associated governance framework. The report also contains a number of recommendations.

Key messages

The expert review group was able to identify the progress made by NHS boards in implementing the guidance. The commitment of the service to critical analysis, evaluation and service improvement was clearly demonstrated. The review also demonstrated that NHS boards and regional cancer networks have systems in place to support the safe delivery of SACT services.

Published Date: 14 June 2017